NORTHERN TRUST CORP - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 24 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,000
-57.1%
28,3220.0%0.00%
Q2 2022$7,000
-12.5%
28,3220.0%0.00%
Q1 2022$8,000
-27.3%
28,3220.0%0.00%
Q4 2021$11,000
-38.9%
28,3220.0%0.00%
Q3 2021$18,000
-5.3%
28,3220.0%0.00%
Q2 2021$19,000
-26.9%
28,3220.0%0.00%
Q1 2021$26,000
+30.0%
28,3220.0%0.00%
Q4 2020$20,000
-4.8%
28,3220.0%0.00%
Q3 2020$21,000
+40.0%
28,322
+122.1%
0.00%
Q2 2020$15,000
+87.5%
12,7510.0%0.00%
Q1 2020$8,00012,7510.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 52,301$36,0000.00%
TOWNSQUARE CAPITAL LLC 53,672$37,0000.00%
REILLY FINANCIAL ADVISORS, LLC 17,500$12,0000.00%
NVWM, LLC 2,997$2,0000.00%
Advisory Services Network, LLC 20,500$14,0000.00%
VANGUARD GROUP INC 160,224$112,0000.00%
UBS Group AG 10,353$7,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 25,000$17,0000.00%
Sugarloaf Wealth Management, LLC 2,000$1,0000.00%
OSAIC HOLDINGS, INC. 3,260$3,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders